EB FlevoResearch B.V.

At EB FlevoResearch B.V. in Almere, clinical research in cardiovascular diseases focuses on major heart and blood vessel conditions such as atherosclerotic cardiovascular disease, elevated Lp(a), and broader atherosclerosis-related risk. These studies are designed to assess whether new therapies can reduce serious cardiovascular events and improve long-term outcomes.

• Testing treatments aimed at lowering the risk of major heart-related complications
• Evaluating approaches for people with established cardiovascular disease and high risk factors
• Studying therapies intended to reduce events such as heart attack and stroke

This area also includes research linking cardiovascular health with kidney outcomes, reflecting a broader effort to improve prevention and treatment for people with complex chronic disease.

Research in nutritional and metabolic diseases at this site centers on obesity, overweight, and type 2 diabetes mellitus. The trials are mainly exploring whether new therapies can support weight reduction, improve metabolic control, and lower the risk of complications tied to excess body weight and diabetes.

• Assessing treatments for weight loss and weight management
• Studying therapies for people with type 2 diabetes and elevated cardiovascular risk
• Evaluating whether metabolic treatments can improve long-term health outcomes

These studies reflect a strong interest in the overlap between metabolic health and cardiovascular prevention, with the goal of improving care for people living with multiple related conditions.

The respiratory tract diseases portfolio includes trials in asthma and chronic obstructive pulmonary disease (COPD), including chronic bronchitis. Research here is focused on improving symptom control and reducing flare-ups in people with ongoing breathing problems.

• Testing new options for asthma control in adults with more severe disease
• Evaluating add-on treatments for COPD to reduce exacerbations
• Supporting research aimed at better management of chronic lung disease

Overall, the respiratory studies at EB FlevoResearch B.V. are aimed at finding more effective ways to prevent worsening disease and improve day-to-day respiratory health.